Lypro BioSciences

2929 7th St, Ste. 120

Berkeley

Established 2004

Lypro’s nano-based drug technology is designed to increase the solubility and bio-availability of hydrophobic drugs and facilitates drug targeting to specific receptors, enabling drug manufacturing companies to receive next-generation drug delivery technologies.